Trial intelligence / Profile preview

Acupuncture to Prevent Chemobrain in Breast Cancer

NCT02457039Completed

Sponsor
The University of Hong Kong
Start
Oct 2015
Primary completion
Dec 2018
Countries
2
01

Overview

Randomised, single-blind trial (2 arms), sponsored by The University of Hong Kong. Primary endpoints: Changes in cognitive function (objective measurement) at 8 weeks and Changes in cognitive function (subjective measurement) at 8 weeks. Started Oct 2015; status: completed.

Beyond the preview

Go deeper on NCT02457039.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02457039.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call